Furthermore, the comprehensive PPI and molecular docking analysis showed that the six key targets (ALB, ESR1, CASP3, EGFR, JUN and TP53) related to HCC had significant binding abilities with formononetin. The gene discussed is EGFR; the disease is hepatocellular carcinoma.